Novo Nordisk NVO faced a significant setback in July after sharply reducing its 2025 outlook for both sales and operating ...

What is being described as a groundbreaking discussion in the medical industry is linking hearing loss with dementia.

More than one in five UK adults tried to access weight-loss medications in the past year alone, according to a survey by the ...

Amgen stock dropped Wednesday despite a strong second quarter as investors look ahead to the next weight-loss readouts.

Amgen Inc. (NASDAQ:AMGN) shares are trading lower on Wednesday, despite the company reporting second-quarter results that ...

Amgen on Tuesday posted quarterly financial results that beat Wall Street expectations as a 9% increase in product sales ...

Thousand Oaks-based Amgen saw shares dip about 5% on Aug. 6, the day after the company’s earnings announcement, though not because of the earnings themselves but rather about news of its weight-loss ...

Amgen on Tuesday posted quarterly financial results that beat Wall Street expectations as a 9% increase in product sales offset higher operating expenses. The California-based biotech company's second ...

A pilot program by the Centers for Medicare and Medicaid could increase coverage for weight-loss drugs like Ozempic and Zepbound. The pilot program would allow state Medicaid programs and Medicare ...

A pilot program by the Centers for Medicare and Medicaid could increase coverage for weight-loss drugs like Ozempic and Zepbound. The pilot program would allow state Medicaid programs and Medicare ...